Harvest Fund Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Harvest Fund Management's DGX Position: Q2 2026 in Review
Harvest Fund Management reduced its Quest Diagnostics (DGX) stake by 2.6% in Q2 2026, selling an estimated $2.35K and leaving 451 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #300.
Harvest Fund Management first reported a position in DGX in Q4 2016 and has held it in 26 quarters since. The position peaked at $854K in Q1 2025. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Harvest Fund Management held 451 shares of Quest Diagnostics worth $96K as of Q2 2026.
- Harvest Fund Management sold 12 Quest Diagnostics shares in Q2 2026, an estimated $2.35K.
- Quest Diagnostics made up ﹤0.01% of Harvest Fund Management's portfolio in Q2 2026, its #300 holding.
- Harvest Fund Management first reported a position in Quest Diagnostics in Q4 2016 and has held it in 26 quarters since.
- Harvest Fund Management's Quest Diagnostics position peaked at $854K in Q1 2025.
- 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.